CRO support for ncats drug product development, manufacture, and stability studies

Ended Awarded Last action

Contract number
HHSN271201700022I
Awardee
Awarding agency
Task orders
1 $704,709 obligated

Award facts

Combined order value
$704,709 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 5% used
$14,444,775.00
Award type
Multiple award
Who can order
Only the awarding agency
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

Task orders

Task order Ordering agency Obligated Awarded
Dosage form development, manufacture, and stability studies of mitragynine 75N95020F00001 National Institute on Drug Abuse (NIH) $704,709

Transactions

Action Obligated Date
Other Administrative Action P00006 $0
Supplemental Agreement for work within scope P00005 $0
Supplemental Agreement for work within scope P00004 $0
Funding Only Action P00003 -$5,000
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $5,000

Quick answers

Who was awarded contract HHSN271201700022I?

HHSN271201700022I was awarded to Purdue University by National Institute on Drug Abuse (National Institutes of Health) on July 26, 2017.

How much is contract HHSN271201700022I worth?

Orders under HHSN271201700022I have obligated $704,709. HHSN271201700022I's own ceiling is $14,444,775.

How many orders have been placed under contract HHSN271201700022I?

1 order has been placed under HHSN271201700022I, the latest on September 18, 2020.

Which agency awarded contract HHSN271201700022I?

National Institute on Drug Abuse (National Institutes of Health) awarded HHSN271201700022I, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Who can order from contract HHSN271201700022I?

HHSN271201700022I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN271201700022I part of a contract vehicle?

Yes. HHSN271201700022I is part of NCATS Drug Product Development Studies 2017-2022.

Was contract HHSN271201700022I competed?

The extent of competition for HHSN271201700022I was full and open competition. The government received 4 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV